Cencora (COR) Q4 FY25 earnings call

Cencora delivered robust Q4 FY25 results, driven by strong performance in its U.S. Healthcare Solutions segment and strategic focus on specialty. The company raised its long-term adjusted operating income and EPS growth guidance, reflecting confidence in its market positioning and MSO platform strategy. A strategic portfolio review led to the creation of an "other" segment for businesses under evaluation, aiming to sharpen focus on core growth areas.